Serocit 46.7% Injection contains an active component as Sodium Citrate. This medication is commonly used for various purposes, primarily in managing acidosis and as an anticoagulant for certain medical procedures. Acidosis occurs when the body's pH becomes too acidic due to an imbalance in the body's production or elimination of acids. Various factors, such as uncontrolled diabetes, kidney dysfunction, or severe dehydration, can cause this condition. This medication helps to neutralize excess acid in the blood, thus restoring the pH balance. Serocit 46.7% Injection is used as an anticoagulant in some medical procedures, particularly when blood needs to be drawn or stored outside the body. It prevents blood clotting, essential for certain diagnostic tests and blood transfusions. One of the common applications is in preparing blood products like packed red blood cells or platelets for transfusion.

You should avoid using this medication if you have a known hypersensitivity or allergy to Serocit 46.7% Injection or any of its components. It can affect the levels of electrolytes in the body, such as sodium and potassium. Therefore, caution should be exercised in individuals with conditions that may lead to electrolyte imbalances, such as kidney problems or heart failure. Individuals with impaired kidney function should use it cautiously, as it may affect the body's ability to handle electrolyte balance. People with certain gastrointestinal disorders, such as gastric outlet obstruction or severe inflammatory bowel disease, should avoid using Serocit 46.7% Injection. Special care and appropriate dosage adjustments may be required in children or elderly individuals.

Serocit 46.7% Injection is used to treat the following:

• Metabolic acidosis
• Anticoagulant for medical procedures

By administering Serocit 46.7% Injection by injection, healthcare professionals can help neutralize the excess acid, restoring the body's pH balance and alleviating symptoms associated with acidosis, such as rapid breathing, confusion, and fatigue.

By inhibiting the coagulation process, this medication ensures that the blood remains in a liquid state, facilitating the success of these procedures and reducing the risk of complications related to clot formation.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Serocit 46.7% Injection, reducing effectiveness by causing undesirable side effects. 

• Store at room temperature, between 15°C to 30°C (59°F to 86°F).
• Keep away from moisture, heat, and light.
• It should not be frozen.
• Keep away from children and pets.

To use Serocit 46.7% Injection, follow the instructions provided by your healthcare professional or as indicated on the product label. This medication is typically administered intravenously under medical supervision to treat metabolic acidosis. The dosage will be determined based on your specific condition and needs. It is added to blood products for anticoagulant purposes during medical procedures to prevent clotting. 

Serocit 46.7% Injection causes some side effects like all medications, although not everyone will experience them. 

Serious:

• Allergic reactions (rash, itching, swelling, severe dizziness, difficulty breathing)
• Electrolyte imbalances (unusual weakness, irregular heartbeat, muscle cramps, seizures)
• Signs of infection at the injection site (if used intravenously)
• Severe abdominal pain or discomfort
• Signs of dehydration (excessive thirst, dry mouth, decreased urine output)

Common:

• Nausea
• Vomiting
• Diarrhea
• Abdominal discomfort
• Bloating
• Excess gas (flatulence)

Advice regarding Serocit 46.7% Injection is to consult with a healthcare professional before starting or making any changes to your medication regimen. They can assess your medical history, evaluate potential risks and benefits, provide personalized guidance, and monitor your progress throughout treatment. Additionally, closely follow your healthcare provider's instructions and recommendations, promptly report any unusual or concerning symptoms, and communicate openly about any concerns or questions you may have. Precautions should be taken when using this medication in patients with liver or kidney impairment, as dosage adjustments or special monitoring may be required. Pregnant and breastfeeding individuals should consult with healthcare professionals before using this medication. Your healthcare professional is the best resource for ensuring safe and effective medication use. Special cautions are required in pediatrics and geriatrics.

1. National Center for Biotechnology Information, PubChem Compound Summary for CID 6224, Serocit 46.7% Injection; [Published date: July 2023] [Accesses: 22/July/2023]; https://pubchem.ncbi.nlm.nih.gov/compound/Sodium-citrate
2. KD Tripathi, Essentials of Medical Pharmacology, Drugs affecting coagulation, bleeding and thrombosis, 7th edition, 2013, 617.
3. La Renon Healthcare Pvt Ltd; [Accessed on 22/July/2023]; http://www.larenon.com/wp-content/uploads/2017/12/Serocit.pdf
4. Terumo BCT, Inc, US Food and Drug Administration, [Issued on 2016] [Accessed on 22/July/2023], https://www.fda.gov/media/114460/download
5. Johan Vande Walle et al.; Sodium Citrate 30 years in clinical use: A safety review; [Revised: 2007] [Accessed: 22/July/2023]; https://pubmed.ncbi.nlm.nih.gov/18690973/